Literature DB >> 28546795

Common Chronic Complications Following Inflammatory Bowel Disease Surgery.

Scott A Strong1.   

Abstract

Entities:  

Year:  2017        PMID： 28546795      PMCID： PMC5441025     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  6 in total

1.  Clinical Practice Guideline for the Surgical Management of Crohn's Disease.

Authors:  Scott Strong; Scott R Steele; Marylise Boutrous; Liliana Bordineau; Jonathan Chun; David B Stewart; Jon Vogel; Janice F Rafferty
Journal:  Dis Colon Rectum       Date:  2015-11       Impact factor: 4.585

2.  Postoperative Medical Management of Crohn's Disease: Prevention and Surveillance Strategies.

Authors:  Miguel Regueiro; Scott A Strong; Linda Ferrari; Alessandro Fichera
Journal:  J Gastrointest Surg       Date:  2016-05-26       Impact factor: 3.452

Review 3.  The Difficult Stoma: Challenges and Strategies.

Authors:  Scott A Strong
Journal:  Clin Colon Rectal Surg       Date:  2016-06

4.  Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.

Authors:  Lauranne A A P Derikx; Wietske Kievit; Joost P H Drenth; Dirk J de Jong; Cyriel Y Ponsioen; Bas Oldenburg; Andrea E van der Meulen-de Jong; Gerard Dijkstra; Marina J A L Grubben; Cornelis J H M van Laarhoven; Iris D Nagtegaal; Frank Hoentjen
Journal:  Gastroenterology       Date:  2013-09-25       Impact factor: 22.682

5.  Clinical course of cuffitis in ulcerative colitis patients with restorative proctocolectomy and ileal pouch-anal anastomoses.

Authors:  Bin Wu; Lei Lian; Yue Li; Feza H Remzi; Xiuli Liu; Ravi P Kiran; Bo Shen
Journal:  Inflamm Bowel Dis       Date:  2013-02       Impact factor: 5.325

Review 6.  Anti-Tumor Necrosis Factor-α Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position Paper.

Authors:  Stefan D Holubar; Jennifer Holder-Murray; Mark Flasar; Mark Lazarev
Journal:  Inflamm Bowel Dis       Date:  2015-11       Impact factor: 5.325
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.